Medical technologies to diagnose cancer, such as scanners and AI models, will be trialled in the UK following funding from the government and support from industry partners.
In a press release, published on 6 October…
What You Should Know:
– Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk assessment completion through a collaboration with CancerIQ, a best-in-class cancer-focused…
Continue Reading
Introduction
In a significant advancement for personalized medicine, GE HealthCare’s MIM Software has received FDA 510(k) clearance for its Theranostics portfolio. This clearance allows MIM SurePlan MRT to perform absorbed dose calculations using the Monte…
Siemens Healthineers has received FDA Premarket Approval (PMA) for its cutting-edge Mammomat B.brilliant mammography system. This innovative system integrates new 3D image acquisition and reconstruction technology, setting a new standard for breast cancer screening….
Continue Reading
Breast cancer treatment has evolved rapidly over the years, with technological advancements playing a critical role in improving patient outcomes. A groundbreaking study recently presented at the American Society of Radiation Oncology (ASTRO) annual…
Continue Reading
The 81st episode of the CIO podcast hosted by Healthcare IT Today was recorded at the MEDITECH Live conference! We were joined by Nolan Hennessee, CIO and Vice President at St. Joseph's/Candler Health System…
Continue Reading
What You Should Know:
– Cedars-Sinai Cancer is taking a major step towards addressing health disparities by participating in the largest-ever national study focused on cancer risk factors in Asian Americans.
– The initiative, funded by…
Continue Reading
AI biotech company Owkin announced a partnership with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.According to Owkin, BRCA…
Continue Reading
Welcome to the September edition of Digital Health Digest! This month, we cover groundbreaking developments, from Particle Health’s legal battle against Epic to hologram doctor visits at West Cancer Center and Neuralink’s latest FDA…
Continue Reading
Introduction
In recent years, advancements in technology have significantly impacted cancer research and drug discovery. One of the most exciting developments is the collaboration between MedTech startup Imagene AI and Oracle, which leverages artificial intelligence…
